PP
Pradnya Pranav Nagarnaik
About Pradnya Pranav Nagarnaik
Data last updated:
Pradnya Pranav Nagarnaik has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Qualichem Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Qualichem Laboratories Private Limited at ₹3.06 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Qualichem Laboratories Private Limited U73100MH2010PTC201124 | Director | 10 Sep 2019 | 2010 | ₹3.06 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pradnya Pranav Nagarnaik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pradnya Pranav Nagarnaik
Pradnya Pranav Nagarnaik has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Qualichem Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Qualichem Laboratories Private Limited at ₹3.06 Cr (FY 2025).
Pradnya Pranav Nagarnaik is associated with 1 company as Director, including Qualichem Laboratories Private Limited (₹3.06 Cr).
Pradnya Pranav Nagarnaik has expertise in General Business.
Pradnya Pranav Nagarnaik has 7 years in corporate governance.
By reported revenue, the largest current company of Pradnya Pranav Nagarnaik is Qualichem Laboratories Private Limited, with revenue of ₹3.06 Cr (FY 2025).
Pradnya Pranav Nagarnaik currently holds positions at 1 company: Qualichem Laboratories Private Limited (₹3.06 Cr).